Drawing for DIGITAL INNOVATION

USPTO serial 79364205

DIGITAL INNOVATION

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
WUDARSKY, MINDY CHEK
Law office
LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with DIGITAL INNOVATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

B. Brett Heavner

B. Brett Heavner Finnegan, Henderson, Farabow, Garrett,901 New York Avenue, NWWashington, DC 20001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009downloadable computer software for use in clinical trials and in clinical development in pharmaceutical field; downloadable computer software and downloadable computer application software for mobile phones and portable computers for providing, analyzing and generating reports; downloadable computer software and downloadable computer application software for mobile phones and portable computers for data processing; downloadable computer software and programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; downloadable computer software for analytics in the fields of healthcare, pharmaceutical preparations and biomedical research, and for clinical trial data; downloadable computer software and downloadable computer application software for mobile phones and portable computers for use in clinical trials and in clinical development in pharmaceutical field featuring electronic computer databases of pharmaceutical preparations and research and medical information; downloadable computer software and downloadable computer application software for mobile phones and portable computers for management of pharmaceutical research; computer software and downloadable computer application software for mobile phones and portable computers for accessing, controlling and managing data and information related to healthcare services, pharmaceutical preparations and research and patient medical information; downloadable computer software and downloadable computer application software for mobile phones and portable computers for measuring, monitoring, processing and tracking health, wellness and medical information; downloadable computer software and downloadable computer application software for mobile phones and portable computers for obtaining and providing updated scientific, medical and clinical information, and for obtaining and providing information related to disease awareness and pharmaceutical preparations and research; downloadable computer software and downloadable computer application software for mobile phones and portable computers for accessing and analyzing data and information related to healthcare services, pharmaceutical preparations and research and patient medical information, and for controlling and managing data and information related to healthcare services, pharmaceutical preparations and research and patient medical information; electronic database recorded on computer media containing pharmaceutical, medical, healthcare, and life sciences information; digital materials, namely, downloadable audio, audio-visual, video, and text files providing pharmaceutical, medical, healthcare, and life sciences information and analysis; downloadable electronic publications in the nature of brochures, reports and white papers in the pharmaceutical, medical, healthcare and life sciences fields; downloadable image files containing analysis supporting clinical development activities; downloadable electronic publications in the nature of journal articles and web publications in the field of healthcare and pharmaceuticalsACTIVE—
042Analysis of technical business and healthcare data by computers; pharmaceutical and biomedical research services;research in the field of pharmaceutical and biologic therapeutic preparations; software as a service (SaaS) services featuring software for providing scientific research information in the field of pharmaceuticals and biomedicine; providing temporary use of online non-downloadable computer software for use in clinical trials and clinical development in pharmaceutical field featuring electronic computer databases of pharmaceuticals and medical information; providing temporary use of online non-downloadable computer search engine software for accessing and providing updated scientific, medical, pharmaceutical and clinical information; providing temporary use of online non-downloadable computer software for accessing, controlling, analyzing and managing data and information related to healthcare services, pharmaceutical preparations and research and patient medical information; computer programming; providing temporary use of non-downloadable computer programs for use in clinical trials and clinical development in pharmaceutical field on data networks; rental of computers; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; computer-aided scientific research, testing and analysis services in the field of healthcare and pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2026FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 17, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 17, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 16, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 17, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 17, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 4, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 4, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 4, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 3, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 2, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 2, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2023RFNTREFUSAL PROCESSED BY IB—
Jul 28, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 28, 2023RFRRREFUSAL PROCESSED BY MPU—
Jun 22, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 21, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2023DOCKASSIGNED TO EXAMINER—
Mar 7, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 2, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance